Design, synthesis, and biological evaluation of BODIPY-based photoactivatable Crizotinib prodrugs for precision cancer therapy
{{output}}
Crizotinib is an established first-line therapy for patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC). However, long-term treatment is often associated with systemic toxicity, leading to various adverse effects... ...
